The U.S. Food and Drug Administration will begin removing broad “black box” warnings from hormone replacement therapy products for menopause, the Department of Health and Human Services announced. HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, M.D., …
